Semaglutide· 5mg
GLP-1 agonist
Vendor VerdictScore
Our Rating — VialVerdict's internal supplier score until more customer reviews are available.
Product + vendor context
Semaglutide from Apollo
This page covers Semaglutide as sold by Apollo. Product-specific reviews are only counted when a reviewer selects this exact vendor/product pair. Vendor reviews, external review signals, and the vendor VerdictScore are shown separately so broad vendor reputation does not masquerade as product-specific proof.
Semaglutide is a once-weekly GLP-1 receptor agonist, marketed as Ozempic for type 2 diabetes and Wegovy for weight management. As the original blockbuster GLP-1 drug, it has the most extensive real-world safety and efficacy data of any peptide in the weight-management space.
Current catalogue snapshot: 5mg vial, $79.99 total, $16.00/mg, listed in stock. VialVerdict does not yet have a published purity value for this row; confirm the latest COA before ordering.
Frequently asked questions about Apollo Semaglutide
Is Apollo Semaglutide reviewed separately from vendor reviews?
What does VialVerdict know about this Semaglutide listing?
Why show vendor reviews on a Semaglutide product page?
Does VialVerdict earn from Apollo links?
Vendor-level reviews for Apollo
These reviews describe the vendor overall — shipping, packaging, support, and fulfilment — not necessarily this exact Semaglutide listing.
Other vendors selling Semaglutide
Ranked by rating, price, and listed product data.